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Abstract

Candida albicans is an opportunistic pathogen that is present in the normal flora
in a majority of individuals. One key factor in C. albicans virulence is the ability to
change its morphology from yeast to an elongated or hyphal form. The regulation of
this morphogenesis relies in part upon quorum sensing (QS) molecules. C. albicans
often exists as part of a mixed culture alongside other fungi and bacteria and is
influenced by their presence as well as the presence of QS molecules that they
produce. It has previously been demonstrated, using haploinsufficient mutants, that a
library screen of Candida albicans can be utilized to identify genetic elements involved
in response to bacteria.2 In this study, a library of diploid homozygous transcriptional
regulator knockout (TRKO) mutants were screened to identify strains capable of forming
hyphae in the presence of Pseudomonas aeruginosa, Staphylococcus aureus, and
Escherichia coli. We identified three strains that showed increased hyphae
development compared to wild type C. albicans. The strains identified had deletions of
the transcriptional regulating genes Orf19.3928, Orf19.2842 (GZF3), and Orf19.3865
(RFX1).4 These strains were tested for alterations of filamentation in liquid media, and
biofilm formation. All three strains showed increased rates of biofilm formation
compared to the wild type. Orf19.3928 showed altered response to farnesol, a marked
in biofilm formation and no inhibition of filamentation when farnesol was present in liquid
media. The GZF3 deletion strain showed enhanced filamentation with all three bacterial
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species while the RFX1 deletion strain showed increased filamentation only with E. coli
and S. aureus. In spent media, GZF3 showed slight increases in filamentation in E. coli
and S. aureus while RFX1 had moderate increases in filamentation in E. coli and S.
aureus and slight increases with P. aeruginosa.
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Introduction

Candida species are eukaryotic, unicellular yeast, in the Family Saccharomycetaceae. They are commonly isolated from humans and often exists as a part of our
natural flora in the mouth, gastrointestinal tract, and female genitourinary tract.15 In
recent years it has been reported that Candida species are the fourth most common
nosocomial infection8 , which may be in part due to the rise in the use of broad spectrum
antibiotics.23,15 Many species of Candida are not pathogenic, however several are able
to cause disease in humans (Table 1). One species, C. albicans, causes the majority of
infections and may be present in the oral cavity of up to 75% of the population.13
Candida that exists as part of our natural flora usually does not cause disease due to
competition with the many other commensal organisms that exist in our microbiome.
The use of broad spectrum antibiotics, while effectively eliminating the desired target
organism responsible for disease, may also unintentionally eliminate aspects of our
natural flora that help to control the levels of C. albicans.23,15 This can lead to
overgrowth of C. albicans which can then establish an opportunistic infection. These
opportunistic infections are seen more often in nosocomial settings and in immune
compromised individuals such as premature infants, or those with AIDS, or diabetes.8
Candidiasis
Candida infections can be separated into two categories: superficial infections
and systemic infections. Superficial infections are usually mild and self-limiting and are
often seen in the mucous membranes of the mouth or genitourinary tract, causing
4

thrush and vulvovaginal candidiasis.13 The less common systemic infections, or
candidemia, are much more severe and are more likely to occur in hospital settings due
to invasive procedures such as catheter placement.7 Systemic infections are also more
common in those with compromised immune systems, although individuals with normal
immune responses can also develop Candida infections.

Candidemia mortality rates

have been reported to be more than 35%, with C. albicans species causing more than
45-68% of all candidemia.7,17 The ability of C. albicans to cause disease in such a wide
spectrum of the population makes it important to understand factors that contribute to its
virulence.
Species

Frequency

Morphology

Ploidy

C. albicans

68%

Yeast, Pseudohyphae, Hyphae

Diploid

C. glabrata

11.3%

Yeast, Pseudohyphae

Haploid

C. tropicalis

7.2%

Yeast, Pseudohyphae, Hyphae

Diploid

C. parapsilosis

6.0%

Yeast, Pseudohyphae

Diploid

C. krusei

2.4%

Yeast, Pseudohyphae

Diploid

C. guilliermondii

0.7%

Yeast, Pseudohyphae

Haploid

C. lusitaniae

0.6%

Yeast, Pseudohyphae

Haploid

C. kefyr

0.5%

Yeast, Pseudohyphae

ND*

C. famata

0.2%

Yeast, Pseudohyphae

Haploid

C. inconscipua

0.2%

Yeast, Pseudohyphae

ND*

C. rugose

0.2%

Yeast, Pseudohyphae

Haploid

C. dubliniensis

0.2%

Yeast, Pseudohyphae, Hyphae

Diploid

C. norvengesis

0.1%

Yeast, Pseudohyphae

ND*

Table 1. Pathogenic Candida species.17
Candida species, their frequency observed as human pathogens, possible morphologies, and genetic
organization.
*--Not Determined
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Virulence
In order to cause disease C. albicans relies upon several virulence factors
including adhesins, invasins, secreted proteases and hydrolytic enzymes.13 Another
important virulence trait that C. albicans possesses is the ability to undergo a change in
its morphology from a unicellular yeast to a hyphal or pseudohyphal form in response to
environmental
changes (Figure 1).
There are a number
of environmental
conditions that have
been found to
induce hyphal
formation including
starvation, the
presence of serum or N-acetylglucosamine, increased CO2 levels, and pH above 7.13
Morphogenesis is also controlled by the presence of quorum sensing molecules.8 This
polymorphism is key to the organism’s virulence and it has been shown that when C.
albicans is “locked in” to either the yeast or hyphal forms by genetic manipulation that its
virulence is decreased.8 However, recent evidence has also shown that hyphal
formation is co-regulated along with other virulence factors, so it is difficult to say for
certain which factor is causing the decrease virulence.19
Hyphae or pseudohyphae contribute to virulence by invading the host tissues
and destroying macrophages.15 Another important virulence factor is the ability of C.
6

albicans to form biofilms on the tissues of the host organism or on implanted medical
devices.8, 12 Biofilms are microbial communities that form on either natural or abiotic
surfaces.21 They have organized structures and can consist of either a single microbial
species or a mixture of microbes surrounded by an extracellular matrix.21 Cells that are
able to form biofilms often show increased resistance to environmental stress,
antimicrobial agents, and host immune responses.13 C. albicans biofilms consist of both
the yeast and hyphal forms of the organism as well as an extracellular biofilm matrix
composed mainly of β 1,3-glucan (Figure 2).8,13 In many situations C. albicans forms
mixed biofilms with other potential pathogenic organisms and is often co-isolated along
with these bacteria in nosocomial settings, especially from implanted medical devices.12
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Quorum Sensing
The control of C. albicans morphogenesis has been found to be affected, at
least in part, by quorum sensing (QS) molecules. There are several possible chemicals
that have been identified as possible
QS molecules in C. albicans including
phenylethyl alcohol, tryptophol,
morphogenic autoregulatory substance (MARS), tyrosol, and farnesol.8 Of these
compounds, farnesol (Figure 3) seems to play one of the most crucial roles and is
responsible for inhibiting hyphal formation, and much research has been conducted to
determine its mechanism of action. As cell density increases, the amounts of farnesol
eventually reach a threshold at which the yeast-hyphal transition is inhibited.8, 13
Farnesol levels also play a vital role in the ability of C. albicans to form biofilms through
its control of hyphal initiation. Cells grown at high farnesol concentrations show less
attachment to surfaces and lower levels of biofilm formation.20 Farnesol may, however,
increase disseminated infection by leading to the release of planktonic yeast cells from
a mature biofilm.20 Farnesol has also been shown to have strong antibacterial and
antifungal properties and likely plays a role in cross-kingdom interactions.1
Candida-Bacterial Interactions
C. albicans often forms mixed biofilms and is co-isolated with other
microorganisms. It is also estimated that >20% of bloodstream infections of Candida
also involve a secondary bacterial infectious agent; therefore, the interactions that occur
with other microbes must also be considered.19 Some of these interactions between
microorganisms appear to be mutualistic while others can be antagonistic. In some
8

instances direct cell contact is needed to influence the other organism, while in others
they affect each other indirectly, through competition for nutrients, or by secretion of
molecules such as toxins or QS molecules.19 Many species of bacteria have been
shown to inhibit filamentation by the production of QS molecules including:
Pseudomonas aeruginosa, Lactobacillus rhamnosus, Saccharomyces
boulardii, Burkholderia cenocepacia, Xanthomonas campestris, Acinetobacter
baumannii, Salmonella enterica Serovar Typhimurium, and Streptococcus mutans.19
Pseudomonas aeruginosa is often co-isolated with C. albicans from the lungs of
cystic fibrosis patients, the wounds of burn victims, and from catheter-related biofilms.19
Hyphal formation is inhibited by QS molecules 3-oxo-C12 homoserine lactone (HSL)
and dodecanol produced by Pseudomonas.5,19 Pseudomonas has also been shown to
destroy hyphae by forming a biofilm on the hyphal filaments, restricting their growth and
causing death of the hyphal cell.5,16 It has also been found that C. albicans has an
antagonistic effect on P. aeruginosa. Farnesol, the secreted QS moledule produced by
C. albicans inhibits swarming motility and impacts the synthesis of PQS in P.
aeruginosa which is needed for the synthesis of pyocyanin, an importance virulence
factor that is toxic to C. albicans.10,21 (Figure 4). This dual relationship likely is reflective
of the fact that farnesol concentrations increase with cell density, so inhibition of PQS is
probably not seen in many infections because the cell concentration is initially low.
In oral bacteria it has been shown that the production of trans-2-decenoic acid
produced by S. mutans inhibits filamentation while AI-2 produced by S. gordonii
stimulates filamentation and biofilm production.19 Another organism that has been
shown to alter the morphology of C. albicans is E. coli. It has been reported that the
9

presence of E. coli lipopolysaccharide (LPS) is detected directly by C. albicans and
results in an increase in hyphae formation, contributing to C. albicans virulence.12,17 It
has also been reported that prior colonization with E. coli enhances adhesion of C.
albicans to bladder mucosa.16,21
In laboratory settings, E. coli appears to inhibit hyphal formation in growing C.
albicans colonies, as do the other bacterial species S. aureus and P. aeruginosa.2 The
degree of inhibition varies among these different species and the mechanisms involved
are still not completely understood. Better understanding of these cross- kingdom
interactions is important and may lead to new ways to prevent or treat these infections.

Figure 4. P. aeruginosa and C. albicans interactions.
Complex interactions seen between P. aeruginosa and C. albicans involving QSMs
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Recently, research has been conducted in order to identify genes involved in
cross-kingdom interactions between C. albicans and bacterial species. In a study by
Fox et al., a haploinsufficient C. albicans mutant library was screened to identify genes
involved in the regulation of hyphae production in the presence of P. aeruginosa,
Staphylococcus aureus, and E. coli.2 In this current study, a deletion library of C.
albicans genes involved in transcriptional regulation was screened in order to identify
mutants capable of producing hyphae in the presence of the same bacterial strains.
These three bacterial strains were chosen because they are often co-isolated along with
Candida albicans and identification of genes with altered morphologies in the presence
of all three bacteria would more likely indicate that the gene is involved in a global
response to bacteria. Colony morphology was examined to identify genes causing
alterations in C. albicans morphology resulting in abnormal colony appearance. The
genes identified were subjected to filamentation tests in liquid media, and biofilm
formation assays to investigate how these genes influenced interactions between C.
albicans and the bacterial species.
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Materials and Methods

Strains
Diploid C. albicans transcriptional regulator knockout mutants (TRKO)
constructed by Homann, et. al.6 were obtained from the Fungal Genetics Stock
Center.14 Freezer stocks were inoculated into liquid YPD and grown overnight for
further testing. Wild type C. albicans SC5314 was used as a control microorganism.
The three bacterial strains used were E. coli (ATTC#33922), P. aeruginosa
(ATTC27853), and S. aureus (ATTC#25923).
Media, and growth conditions
The yeast strains were cultured on Yeast Peptone Dextrose (YPD) media (20g
dextrose, 20g peptone, 10g yeast extract, 20g bacto agar in 1L dH2O) at 30° C
overnight. The bacterial strains were maintained on Luria Broth (LB) medium (10g
tryptone, 10g NaCl, 5g yeast extract, 20g bacto agar in 1L dH2O) at 37°C. For
filamentation testing Medium 199 (9.5g M199, 18.7g Tris Buffer, 18g bacto agar, 25 mg
Arganine, pH7.5 in 1L dH2O) was utilized.

Farnesol was prepared weekly in ethanol

and was added to M199 at a 300 μM concentration.
Screen for filamentous mutants
The library of TRKO mutants were individually spot replicated with two centimeter
spacing onto YPD, M199, or M199 plates pre-coated with bacterial lawns from fresh
culture grown overnight at 37° C with shaking. The YPD plate served as a positive
12

control for growth and negative control for filamentation and was grown at 30° C for 48
hours. The M199 plates were incubated at 37° C and were observed at 5-7 days. The
plates were observed under light microscopy for filamentation. The screen was
repeated twice and knockouts that consistently showed filamentation with all three
bacterial species were identified.
Filamentation in liquid media
The TRKO mutants identified as filamentous with bacteria in the library screen
were tested for filamentation in liquid media. The strains were grown aerobically
overnight in liquid YPD at 30° C with shaking, harvested by centrifugation, washed three
times with sterile dH2O and counted with a hemocytometer. Pre-warmed M199 was
inoculated with 5x105 cells/mL with four conditions: M199 with no bacteria, and M199
with overnight growth of E. coli, S. aureus, and P. aeruginosa. The C. albicans strains
were incubated for 3 hours at 37° C, were centrifuged to concentrate the cells, and a
morphology assessment was performed with a light microscope. The filamentation
assay was also performed utilizing spent media. M199 containing overnight bacterial
growth were centrifuged for 8 minutes at 8,000x g and the media was then aspirated,
leaving pelleted bacteria. Centrifugation was then repeated, along with aspiration, to
ensure removal of the maximum amount of bacterial cells. The spent media was then
inoculated with the C. albicans strains at 5x105 cells/mL and were incubated for 3 hours
at 37° C and were observed for cell morphology. A filamentation assay was also
performed with 300 μM Farnesol present in the M199. Farnesol was added to the prewarmed M199 media and was then inoculated with C. albicans strains at 5x105
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cells/mL. These cultures were incubated at 37° C for 3 hours and morphology was
assessed.
Biofilm formation
To assess for biofilm formation the method described by Peeters, et. al. was utilized.18
Briefly, a 96 well plate was prepared by placing 100μL 5% Fetal Bovine Serum (FBS)
into each well and was refrigerated overnight. The yeast to be tested was inoculated
into liquid YPD and was grown overnight at 30° C with shaking. The cells were isolated
via centrifugation, washed three times with sterile water and counted with a
hemocytometer. A serial dilution of the cells (1x105, 1x104, 1x103, 1x102) was then
prepared in pre-warmed M199.
After removal of the FBS, the diluted cells were placed into the 96 well plate in
triplicate and were incubated at 37°C for 90 min to allow cells to adhere. At the end of
the 90 minute period the M199 was removed and the wells were gently washed with
100μL sterile water to release any unadhered cells, then 150μL of sterile, pre-warm M199 was added to each well. The plates were wrapped with parafilm and incubated at
37°C for 48 hours. At the end of the 48 hour period the M199 was removed from the 96
well plate with a vacuum tip. In order to remove any unadhered, planktonic cells each
well was gently washed with 100μL sterile water. The cells were then fixed by adding
100μL ethanol to each well for 10 minutes. After 10 minutes the ethanol was removed
with the vacuum tip and the plate was allowed to air dry for 20 minutes. The remaining
adhered cells in the biofilm were stained with 0.0076% crystal violet for 15 min. The
stain was removed with vacuum tip. 150μL 33% acetic acid was placed into each well
and absorbance was measured at 590 nm. This biofilm procedure was repeated to test
14

biofilm formation in the presence of farnesol by adding pre-warmed M199 containing
300 μM farnesol to the wells following cell adhesion.
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Results
Identification of three transcriptional regulators by a homozygous deletion
screen.
In order to identify genetic elements involved in response to the presence of the
bacteria or their secreted products we first performed a library screen of the TRKO
mutants. The library and the control (SC5314) strains were individually spot replicated
onto YPD, M199, and M199 with bacterial lawns. The bacterial strains chosen included
both Gram positive and Gram negative organisms known to share similar host
environments to C. albicans. The fresh lawns on the M199 plates established a
competitive environment with the C. albicans and would resemble interactions of the
host environment. The YPD plate served as a negative control for filamentation and
was incubated at 30° C, those strains that were observed to be filamentous after 48
hours were removed from the screen. The M199 plate at 37° C was used as a control
for filamentation and those strains that did not show filamentation after 5-7 days were
eliminated from the screen. In total, 364 strains were evaluated and we identified 5
(1.4%) strains as potential candidates for further study as being filamentous in the
presence of all three bacterial species. Four of the strains consisted of duplicate
deletions of identical genes (Orf19.3928,GZF3) while the fifth was a gene for which a
second independent transcription factor deletion was not available (RFX1). Figure 5
shows representative colony morphologies seen in the YPD control as well as on M199
for both wild type organisms and those found to be filamentous with all three bacteria.
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On YPD at 30° C the wild type organisms show typical yeast-type colony morphology
with smooth rounded edges. In contrast, the M199 plate at 37° C shows hyphae
extending from the colony into the surrounding media. In the presence of bacteria,
hyphal formation is inhibited in the wild type strains and the colonies lack hyphal
filaments protruding from the colonies. The TRKO strains identified in our screen
exhibited hyphal growth in the presence of all three bacterial species.

Figure 5. Colony Morphology observed on solid media.
Observed colony morphology of mutant strains showing hyphal extension increases in bacterial presence
compared to the wild type. Strains denoted with –X or –Y are independent isolates of the same gene
deletion identified from this screen.
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Filamentation in Liquid media
In addition to the ability to filament on solid media, we tested the ability of the genetic
mutants to filament in liquid media. C. albicans mutants were grown overnight and
inoculated at 5x105 concentration into M199 at 37°C to induce hyphae formation. The
TRKO mutants were tested in M199 in three conditions: M199 with overnight bacterial
growth of P. aeruginosa, S. aureus, and E. coli; Spent M199 (overnight bacterial growth
with cells removed); and M199 with 300 μM farnesol. We found that the gene deletion
of Orf19.3928 showed enhanced filamentation in liquid when cultured alongside E. coli
and S. aureus, but showed filamentation rates similar to the wild type when cultured
with P. aeruginosa. The GZF3 deletion strain showed enhanced filamentation with all
three bacterial species while the RFX1 deletion strain showed increased filamentation
only with E. coli and S. aureus.(Figure 6) In spent media, GZF3 showed slight
increases in filamentation in E. coli and S. aureus while RFX1 had moderate increases
in filamentation in E. coli and S. aureus and slight increases with P. aeruginosa.(Figure
7) When exposed to farnesol, GZF3 still displayed hyphae formation while RFX1,
Orf19.3928 and the wild type did not.
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Figure 6. Filamentation in the presence of bacteria in liquid media.
Increased in filamentation rates in deletion strains when compared to the wild type. Strains
denoted with –X or –Y are independent isolates of the same gene deletion identified from this
screen.
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Figure 7. Filamentation in spent media.
Some increases in filamentation rates in deletion strains when compared to the wild type. Strains
denoted with –X or –Y are independent isolates of the same gene deletion identified from this
screen.
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Biofilm Formation
We were able to determine the ability of each TRKO strain to form biofilms in M199 with
and without the presence of farnesol over a 48 hour period. Following growth the
biofilms were washed, fixed, and stained. Optical Density (OD) analysis was performed
at 560 nm and we found that all of the strains identified showed increased biofilm
formation with and without the presence of farnesol. RFX1 showed a marked increase
over the other strains when farnesol was not present, but was reduced greatly with the
addition of farnesol. While in the presence of farnesol Orf19.3928 showed the highest
biofilm formation, which is in agreement with the finding that filamentation was seen in
liquid media with farnesol. (Figure 8, 9)
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OD at 590 nm

Biofilm
5
4.5
4
3.5
3
2.5
2
1.5
1
0.5
0
SC5314

Orf19.3928-X
1*10^5

Orf19.3928-Y
1*10^4

GZF3-X

1*10^3

GZF3-Y

RFX1

1*10^2

Figure 8. Biofilm formation without farnesol.
Biofilm formation of mutants compared to wild type, showing increased formation by all mutant strains.
Strains denoted with –X or –Y are independent isolates of the same gene deletion identified from this
screen.

Biofilm with Farnesol
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Optical Density

5
4
3
2
1
0
SC5314

Orf19.3928-X Orf19.3928-Y
1*10^5

1*10^4

GZF3-X
1*10^3

GZF3-Y

RFX1

1*10^2

Figure 9. Biofilm formation in the presence of farnesol.
Biofilm formation of mutants compared to wild type, showing increased formation with mutant strains,
especially Orf19.3928. Strains denoted with –X or –Y are independent isolates of the same gene deletion
identified from this screen.
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Discussion
In recent years, research has revealed how important the microbiome that exists
within our body is to maintain normal function and prevent disease. Imbalances in our
microbiome have been shown to lead to decreases in our natural immunity and
increased risk of infection. The natural flora of our bodies not only provides a
preventative measure against disease but restoring the balance of microbes in our flora
can also be used to treat some infections, such as C. difficile.3 A large part of
understanding how our microbiome works to our benefit as well as contributes to
disease is understanding how all of the organisms that exist in our microbiome interact
with each other and with us. The conversation between these organisms is complex
and we are only beginning to understand a part of the communication that occurs.
Candida albicans is a part of the normal flora and normally its growth is restricted
by the presence of other microbial species or their secreted products. When patients
are treated with broad spectrum antibiotics or are immune compromised these factors
are diminished, which can lead to the establishment of an opportunistic C. albicans
infection.
In C. albicans, it has been demonstrated that quorum sensing plays a role not
only in communication from within the species but also for interspecies communication.
Several genes have been identified to regulate filamentation in C. albicans such as
TUP1, CPH1 and EFG1.1 In addition, genes have also been discovered that play a role
in quorum sensing (QS) in C. albicans. For example, the gene CHK1 has been
23

identified as a key component in the response of the self-regulating QS molecule
farnesol.9 The null mutant (chk1/chk1) and the revertant mutant (chk1/CHK1) both are
able to filament in the presence of farnesol at low cell densities, while the wild type
strain was inhibited by the farnesol.9
While the mechanisms of hyphal formation and quorum sensing have been
studied in depth, relatively little is known about the genetic factors that play a role in C.
albicans interactions with bacteria. Fox et. al. screened a haploinsufficient transposon
insertion library of over 18,000 mutants and identified 107 known/predicted genes that
were involved in Candida albicans/bacterial interactions. The genes fell into several
categories including genes related to enzymatic activity, transport, transcription,
signaling, and adhesion.2
The library screen completed in this study was much narrower in scope and
utilized a library of diploid organisms consisting of only transcriptional regulator deletion
mutants. In this study we identified three total genes involved in bacterial interactions.
The gene located at Orf19.3928 is uncharacterized as of yet. The second gene
Orf19.3865 has been identified as RFX1, a gene involved in DNA repair.4 Hao et. al.,
demonstrated that deletion of RFX2, a similar gene also involved in DNA repair,
resulted in a mutant that was significantly more resistant to environmental stresses such
as UV irradiation, heat shock, and ethanol.11 The third gene Orf19.2842 has been
identified as GZF3, which encodes for a GATA-type transcription factor induced during
oxidative stress.22 A common theme among the named genes that we identified in this
study is that they have been found to be involved in response to stressful environments.
Bacteria living in mixed microbial communities often secrete factors such as acidic
24

products or reactive oxygen species to impair the growth of other microbes. Recent
research has also shown that there is a possible link between quorum sensing and
oxidative stress resistance, with farnesol providing protection against H2O2 and
superoxide anion-generating agents.24 It is unclear how these genes identified may help
protect C. albicans from bacterial competition or if they may be involved in response to
QS molecules. More research is needed to determine the possible mechanisms behind
these interactions so that we can better understand how C. albicans communicates and
regulates its morphology in mixed microbial communities.
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